CCL5 and neoplasm: These anti-tumor immune cell infiltrations by Vps34 inhibition are caused by the upregulation of certain chemokines, CCL5 and CXCL10, thereby improving ICI therapeutic efficacy in melanoma and colorectal cancer mouse models [161].